Our strengths: in tune with today’s challenges

Through its network of excellence, Strasbourg has proved itself to be a prime location for top-level chemistry research: it is one of the top 20 best institutions worldwide and has built skills in subjects that have helped produce concrete solutions for society.

“The University is at the forefront of thinking about scientific, economic and human challenges in today’s world.”

Jean-Marie Lehn, Nobel Prize in Chemistry 1987

Quelques exemples d’avancées scientifiques concrètes des équipes de recherche de Strasbourg :


Materials of the future

picto - materiaux du futur
  • A revolution for chemotherapy: nanocontainers for transporting medication, DNA or enzymes to a specific location thanks to the AXA Chair of over €2.25 million
  • New surprising uses for graphene in the automotive and building industries
  • Micromachines for storing energy and information, which herald the electronics of the future and earned Jean-Pierre Sauvage a Nobel Prize in 2016

Environment & Renewable Energy

picto - environnement
  • The creation of insulating and waterproof polymers, and biomass packaging, which has countless industrial uses: thank you to PSA, Danone, Soprema and Tereos for supporting us!
  • Advances in the field of green chemistry, particularly for biodegrading organic pollutants
  • New nanomaterials, such as nanotubes, combined with catalyst expertise for producing and storing renewable energy


picto - sante
  • Medication brought to phase 3, the results of which are imminent, to cure lupus, an autoimmune disease that affects more than 5 million people
  • Treating multiple sclerosis, asthma, Crohn’s disease, Sjogren syndrome, Parkinson’s and psoriasis thanks to possible medication within five years
  • In six years, Medalis has helped create five working start-ups and file 12 licensed patents for effective technology transfer in the fight against cancer and inflammation thanks to a unique synergy of skills in biology, chemistry and medicine


10 children suffering from heart defects have already been cured thanks to Strasbourg-based research: new technology created by the European company Xeltis uses Jean-Marie Lehn’s research to make cardiovascular implants made from polymers that grow with the child, avoiding the need for multiple risky operations.